Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Next Round For Commissioner Nominee: Crawford Placed On Hold After Clearing Senate Health Committee

This article was originally published in The Pink Sheet Daily

Executive Summary

The nomination of Acting Commissioner Crawford to the permanent FDA post passed the committee. A full Senate vote will be delayed by a long-anticipated hold placed by Sens. Murray and Clinton, who demand the agency first make a decision on the OTC switch of Barr's Plan B emergency contraceptive.

You may also be interested in...



Von Eschenbach Nominated For FDA Commissioner Under Threat Of Hold

Sens. Clinton (D-N.Y.) and Murray (D-Wash.) demand a decision on Plan B to avoid a hold, employing the same tactic they used during the confirmation of former Commissioner Lester Crawford.

Von Eschenbach Nominated For FDA Commissioner Under Threat Of Hold

Sens. Clinton (D-N.Y.) and Murray (D-Wash.) demand a decision on Plan B to avoid a hold, employing the same tactic they used during the confirmation of former Commissioner Lester Crawford.

FDA's Plan B OTC Switch Decision Deadline Is Sept. 1, HHS' Leavitt Says

Sens. Clinton and Murray lift their hold on FDA Acting Commissioner Crawford's nomination after a letter from HHS secretary says FDA action on Barr's Rx-to-OTC switch application is imminent.

Related Content

Topics

UsernamePublicRestriction

Register

OM004674

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel